Spots Global Cancer Trial Database for nec
Every month we try and update this database with for nec cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Registry on NEN Patients and COVID-19 | NCT04444401 | Neuroendocrine ... COVID-19 | 18 Years - | European Institute of Oncology | ||
Registry on NEN Patients and COVID-19 | NCT04444401 | Neuroendocrine ... COVID-19 | 18 Years - | European Institute of Oncology | ||
Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET) | NCT04720391 | Bone Metastases Neuroendocrine ... | - | European Institute of Oncology | ||
Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD) | NCT03944772 | Non-Small Cell ... | Osimertinib Savolitinib Gefitinib Necitumumab Durvalumab Carboplatin Pemetrexed Alectinib Selpercatinib Selumetinib Etoposide Cisplatin Datopotamab der... | 18 Years - 130 Years | AstraZeneca |